The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to attack. Glioblastoma is one of the most aggressive cancers ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied, and the ...

A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

The initial trio of patients with glioblastoma have begun treatment with ropidoxuridine in a phase 2 clinical trial, ...

Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets were identified by screening for genetic vulnerabilities in patient ...

Glioblastoma is the most common – and the most malignant – primary brain tumor in adults. It's aggressive and incurable. Even with treatment including surgical removal and chemotherapy ...

Glioblastoma is a naturally occurring tumour that belongs to a group of brain tumours called 'gliomas' that originate and grow in the brain and spinal cord. Classified as a grade 4 tumour by the ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients ...